The Gut, the Brain, and Everything Between

Margaret is 74, and she has been taking a probiotic every morning for two years because a segment on morning television told her it was good for her brain. The bottle cost $42 and promised “cognitive vitality.” She cannot tell you whether it has helped. She cannot tell you what strains are in it. She takes it the way she takes her multivitamin: on faith, because doing something feels better than doing nothing.

Margaret is not foolish. She is responding to a real signal buried under a mountain of marketing. There is a genuine biological connection between the gut and the brain, and it does change with age in ways that matter. But what that connection means for a 74-year-old woman trying to protect her memory is considerably more complicated than a bottle of capsules can address.

The Highway Between Your Gut and Your Brain

The gut and brain communicate through multiple channels, and the traffic flows in both directions. The vagus nerve, the longest cranial nerve in the body, provides a direct physical pathway from the intestinal wall to the brainstem. But the conversation also happens through chemistry. Gut bacteria produce metabolites, including short-chain fatty acids like butyrate, that cross into the bloodstream and affect immune function, inflammation, and even the integrity of the blood-brain barrier. They produce neurotransmitters. They shape immune cell behavior. The intestinal lining, when intact, keeps bacterial products contained where they belong. When that lining breaks down, molecules that should stay inside the gut leak into circulation and trigger inflammatory responses that reach the brain.

This communication system has a name: the gut-brain axis. And it is not a metaphor. It is measurable, reproducible biology, confirmed across dozens of animal studies and an increasing number of human observations. The question is not whether the gut and brain talk to each other. The question is how much that conversation matters for the diseases we care about most.

What Happens to the Gut as You Age

The gut microbiome, the community of trillions of organisms living in your intestines, is not static. It shifts throughout life in response to diet, medication, illness, and the aging process itself. In older adults, several changes tend to occur together. Microbial diversity declines. The populations of bacteria that produce short-chain fatty acids, particularly butyrate, shrink. Species associated with inflammation become more prominent. The intestinal lining grows more permeable, a condition researchers sometimes call “leaky gut,” though the term has been so widely misused in wellness marketing that many scientists avoid it.

These shifts matter because they feed into a broader pattern that gerontologists call inflammaging: the chronic, low-grade inflammation that accumulates with age and contributes to cardiovascular disease, diabetes, frailty, and neurodegeneration. The loss of protective gut bacteria is both a contributor to and a consequence of this inflammatory cycle. Studies of centenarians, people who live past 100 in relatively good health, consistently find that they maintain greater microbial diversity and higher levels of the bacteria associated with anti-inflammatory metabolites. That correlation is striking, though whether it is cause or effect remains an open question.

Several factors accelerate these microbial changes. Antibiotics, which older adults receive more frequently, can wipe out beneficial populations. Reduced dietary fiber, common in older adults who eat less or shift toward softer, processed foods, starves the bacteria that depend on it. Polypharmacy, the subject of installment 3G in this series, compounds the problem: proton pump inhibitors, statins, and metformin all alter gut composition in measurable ways.

The Alzheimer’s Connection

Here is where the science gets simultaneously exciting and frustrating. People with Alzheimer’s disease have measurably different gut microbiome compositions than cognitively healthy people of the same age. They tend to have lower microbial diversity, fewer butyrate-producing bacteria, and higher levels of species associated with inflammation. A 2025 umbrella review in npj Dementia that synthesized findings across multiple systematic reviews confirmed these patterns. A separate study published in Alzheimer’s Research and Therapy in early 2025 found that microbiome composition was correlated with accelerated brain aging and cognitive test scores in 292 participants from South Korean memory clinics.

In animal models, the evidence is even more dramatic. Transplanting fecal microbiota from healthy mice into Alzheimer’s model mice has reduced amyloid plaque formation and improved cognitive performance in multiple studies. The reverse also holds: transplanting microbiota from Alzheimer’s model mice into healthy animals can impair their cognition and trigger neuroinflammation. A 2025 study in BMC Neuroscience showed both directions in the same experiment.

But animal models of Alzheimer’s are not Alzheimer’s. The mice carry artificially inserted human gene mutations. Their disease develops on an accelerated timeline. And fecal transplant in a mouse is a vastly simpler procedure than fecal transplant in a human being navigating Medicare.

In humans, the clinical evidence for fecal microbiota transplantation in cognitive decline is limited to case reports and pilot studies involving five to ten patients. One small case-control study found that dementia patients who received fecal transplants for recurrent C. difficile infection showed cognitive improvements compared to those treated with antibiotics alone. Another case report described a woman with Alzheimer’s whose cognitive scores improved modestly after two rounds of fecal transplant. These results are intriguing but far from conclusive. No large randomized controlled trial of fecal transplant for cognitive decline has been completed.

What About Probiotics?

This brings us back to Margaret’s bottle of capsules. A 2025 meta-analysis in BMC Complementary Medicine and Therapies pooled 34 randomized controlled trials involving 2,390 participants and found limited evidence of cognitive improvement from probiotic supplementation at 12 weeks, primarily on the MMSE scale. A separate meta-analysis in the European Journal of Clinical Nutrition found that probiotic effects on cognitive performance were mainly seen in older adults, with modest improvements in processing speed, memory, and spatial ability.

The word “modest” matters here. The effect sizes are small. The studies are heterogeneous: different strains, different doses, different durations, different populations. The 2025 GRADE assessment rated the certainty of evidence as low. And most of the Alzheimer’s-specific trials were conducted in Iran with small sample sizes, limiting generalizability.

None of this means probiotics are useless. It means we do not yet know which strains help, at what doses, for how long, and in whom. A $42 bottle from the drugstore that lists “proprietary blend” on the label is not addressing any of those questions. It is selling hope in a capsule, and hope is a reasonable thing to want, but it is not the same as evidence.

What Actually Helps Right Now

The most consistent evidence for gut-mediated cognitive protection comes not from supplements but from food. The Mediterranean and MIND diets, high in vegetables, fruits, whole grains, legumes, fish, and olive oil, have been associated with slower cognitive decline across dozens of observational studies. The 2025 Dietary Guidelines Advisory Committee reviewed 83 studies and rated the evidence as moderate that these dietary patterns reduce the risk of cognitive impairment and dementia.

These diets work partly through the gut. High-fiber foods feed the bacteria that produce short-chain fatty acids. Polyphenols in berries, olive oil, and leafy greens shape microbial composition in ways that favor anti-inflammatory species. The Mediterranean diet does not target one bacterial strain the way a probiotic capsule does; it reshapes the entire ecosystem.

This is not a glamorous intervention. It does not come in a capsule or require a prescription. For someone caregiving full-time, barely sleeping, eating whatever is fastest, it may feel like one more impossible standard to meet. That frustration is valid. But the evidence points consistently in the same direction: the most reliable way to support your gut microbiome, and through it your brain, is to eat more fiber, more plants, more variety. Not perfectly. Just more.

Where This Science Is Going

Researchers are pursuing several directions. Personalized microbiome interventions, guided by an individual’s specific microbial profile, are in early development. Next-generation probiotics using strains selected for their ability to produce specific metabolites are being tested. The intersection of the gut-brain axis with GLP-1 receptor agonists, covered in installment 3I, is generating interest because semaglutide appears to modify gut microbiome composition and reduce neuroinflammation in early studies.

But these are years from clinical application for cognitive decline. What is available today is dietary fiber, fermented foods, and the uncomfortable truth that the most important organ for brain health might not be in your head.

The next installment will make a related case. The single most evidence-based intervention for nearly every condition covered in this series, from heart disease to depression to the gut microbiome itself, is not a drug, a supplement, or a surgical procedure. It is movement. And the evidence for what it can do in older adults is stronger than most people realize.